The Fed­er­al Trade Com­mis­sion is prais­ing an ap­peals court de­ci­sion call­ing for Te­va to delist five in­haler patents from the FDA’s Or­ange Book.

Orange juice is the world’s most popular fruit juice. Manufacturers produce around 1.6 billion metric tons of this beverage each year. In addition to buying orange juice in many varieties at ...

A device costing just pennies, based on an idea by a University of Manchester Professor to help his son use an inhaler, could be a gamechanger for asthma patients. The impressive results are from ...

The news followed an investigation by POLITICO’s E&E News into climate-friendly inhalers and how drug giants are developing them to undermine competition. The pharmaceutical giant AstraZeneca ...

Two of the four pharmaceutical companies, AstraZeneca and GSK, have announced plans to introduce a new, more environmentally-friendly type of inhaler. These inhalers were expected to be extremely ...

In January 2024, Sanders led the HELP Committee in launching an investigation into the four major manufacturers of inhalers and their efforts to keep prices far higher in America than countries abroad ...

GSK plc's stock downgraded from “Buy” to “Hold” due to litigation risks, disappointing RSV vaccine sales, and competitive pressures in the HIV space. Despite strong cash flow, GSK's Zantac ...

a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of a new patient access program, in partnership with Direct Relief, to supply inhalers to ...

This recipe for bright, sugary slices of candied fruit yields a bonus treat: orange-scented syrup that can be used in drinks, salad dressings, and more. Grace Parisi a former senior test kitchen ...

GSK GSK stock has declined 20.2% in the past three months compared with a decrease of 12.3% for the industry. The stock has also underperformed the sector and the S&P 500 index, as seen in the ...

Big pharma company GSK and UK AI-biotech Relation Therapeutics have entered into two strategic collaborations to identify and validate new therapeutic targets for osteoarthritis and fibrotic diseases.